Lamictal

FDA Decision Encourages Lamictal Generics

As the FDA cannot approve an abbreviated new drug application (ANDA) for a listed drug that has been withdrawn due to reasons of safety or efficacy// , the agency had to determine the reasons for the withdrawal before approving any generic version. The investigation found no evidence of safety...

Analysis Shows Lamictal As An Effective Additional Therapy For Treatment of Grand Mal Seizures

Researchers have shown the effectiveness of Lamictal (lamotrigine) as additional treatment method in children and young people with primary// generalized tonic-clonic (PGTC) seizures. According to the latest issue of the journal Paediatrics, lamotrigine (LAMICTAL) has been demonstrated to be...

PatientAssistance.com Releases the Top 20 Most Popular Searches for Patient Assistance Programs

...lta (412) 7. NEXIUM (390) 8. LIPITOR (389) 9. ABILIFY (361) 10. SINGULAIR (345) 11. TOPAMAX (340) 12. LISINOPRIL (333) 13. lamictal (327) 14. Suboxone (319) 15. SYNTHROID (306) 16. AMBIEN (303) 17. OXYCONTIN (302) 18. METFORMIN HCL (297) 19. EFFEXOR XR (291)...

FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy

...ears of age or older with partial onset seizures. lamictal XR reduced seizures in patients who were inadequately controlled on current therapy. lamictal XR reduced the frequency of partial seizures during a 19-week study. More patients who took lamictal XR had a significant reduction in seizure frequen...

FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets

...(TM) (lamotrigine) Orally Disintegrating Tablets. lamictal ODT uses a novel drug-delivery formulation to provide lamictal in a tablet that has a pleasant taste and disinte...al Sciences. "Orally disintegrating tablets, like lamictal ODT , offer an option for patients who have diffic...

For Bipolar Depression, Surveyed Experts Indicate That Current and Emerging Therapies Have No Advantage Over Seroquel in Decreasing the Severity of Symptoms

... lamictal Will Retain Decision Resources' Clinical Gold Standard Status for Bipolar Depression, According to a New Report from Decision Resources WALTHAM, ...

Surveyed Neurologists in Both the U.S. and Europe Would Welcome an Antiepileptic Drug That is Administered Once-Daily

...gh level of physician comfort in prescribing the drug as an add-on therapy, lamictal became the epilepsy sales leader in 2007, ahead of the 2007 clinical gold s... now launched in the United States, provides improved convenience over both lamictal and immediate-release Keppra while retaining a favorable efficacy and safet...

Despite Availability of Generic Equivalents, Two-Thirds of Neurologists Will Continue to Prescribe Branded Anti-Epileptic Drugs to Epilepsy Patients

...cantly by brand. "Currently, 54 percent of the neurologists we surveyed specify 'no generic substitution' on prescriptions for GlaxoSmithKline's lamictal and a similar proportion indicate they will specify the same on prescriptions for other AEDs when generic versions of these agents become available," ...

GlaxoSmithKline Presents Innovative Neuroscience Pipeline

...in announced -- Four CNS products with potential to be launched or approved in 2008: - Trexima potential "new gold standard" for migraine; - lamictal XR new once daily treatment for epilepsy; - Lunivia, a successful treatment for insomnia in the US, expected to be launched in Europe; -...

Exposure to Epilepsy Drug During Pregnancy Can Increase Risk of Mental Defects in Newborns

...mpared with an average of 96 for children in the Tegretol group, 94 for the lamictal group and 95 for the Dilantin group. After adjusting for the mothers' IQ sc...ers took Depakote had IQs below 70, compared with 13% for Tegretol, 11% for lamictal and 12% for Dilantin. According to researchers, about 2% of all children ha...

Lamictal in Medical Technology

New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy

Investigational Extended-Release Formulation Reduced Seizures in Patients Who Were Inadequately Controlled RESEARCH TRIANGLE PARK, N.C., Oct. 15 /PRNewswire-FirstCall/ -- New recently published data show that Lamictal(R)XR(TM) (lamotrigine) Extended- Release Tablets significa...

New Data Shows Once a Day Lamictal XR is Effective in Treating Patients with Partial Seizures

Data Presented at the American Academy of Neurology Annual Meeting Show Approximately 50 Percent Reduction in Partial Seizures BOSTON, May 01, 2007 /PRNewswire/ -- Data from two clinical trials presented today at the American Academy of Neurology (AAN) meeting suggest that an investigational once ...